Results 171 to 180 of about 307,950 (395)
Duration of Intubation after Coronary Artery Bypass Graft Surgery and Its Related Factors
Background and purpose: Critical care nurses could actively participate in the decision made by the healthcare team especially if they have the knowledge on the factors that affect extubation time following coronary artery bypass surgery.
Hamed Faghani+5 more
doaj
To Pace Or Not To Pace! – Prevention Of Atrial Fibrillation After Coronary Artery Bypass Surgery [PDF]
Atrial fibrillation (AF) is a very undesirable, but unfortunately a common arrhythmia following coronary artery bypass graft (CABG) surgery, occurring in up to 40% of patients.
Vora, Amit
core +2 more sources
Abstract Background and aims The pulmonary artery pulsatility index (PAPi), that is, the pulmonary artery pulse pressure (PAPP) divided by the mean right atrial pressure (mRAP), is an increasingly used invasive index of right ventricular function. We sought to assess the prognostic impact of the PAPi in unselected patients with aortic stenosis (AS ...
Laura A. Rechsteiner+9 more
wiley +1 more source
Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. ARNI, angiotensin receptor/neprilysin inhibitor; CRT, cardiac resynchronization therapy; eGFR, estimated glomerular filtration rate; GDMT, guideline‐directed medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection ...
Clara I. Saldarriaga+21 more
wiley +1 more source
Finerenone and glycaemic status in patients with heart failure with mildly reduced/preserved ejection fraction. CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio; RR, rate ratio. Abstract Aims The efficacy and safety of the non‐steroidal mineralocorticoid receptor antagonist, finerenone, have not been examined in patients
Jawad H. Butt+18 more
wiley +1 more source
Polymorphous Ventricular Tachycardia during Coronary Artery Bypass Surgery [PDF]
Manuel Weiskopf, Stanley W. Stead
openalex +1 more source
Background: Clopidogrel is an adenosine-5' diphosphate (ADP) receptor antagonist that eventually inhibits platelet aggregation. It is used concomitantly with percutaneous coronary interventions and in patients with acute coronary diseases. This study was
Keyvan Bagheri+6 more
doaj